TherapeuticsMD, Inc.
Annual report filed late (NT 10-K)
The company filed Form NT 10-K with the SEC on 01 Apr 2026, notifying investors that its annual report would be late. A late annual report can point to accounting or audit problems, though the reason is sometimes routine.
More details →Change of auditor (8-K Item 4.01)
The company reported a change of its independent auditor in a Form 8-K (Item 4.01) filed on 21 Jan 2026. Auditor changes are often routine (rotation, cost, mergers), but can follow disagreements over accounting.
More details →TherapeuticsMD, Inc. — Overview & Financial Snapshot
TherapeuticsMD, Inc. (NasdaqGS: TXMD) is a Healthcare company, ranked #4,068 of 6,775 companies globally and #1,923 of 4,000 in United States on PositoAI, with a Positivity Score of 19,978. Its market capitalisation is ₹202.12 Cr ($21.41M), P/E ratio is -46.2 and P/B ratio is 0.79. It has no active red flags (PosiRed) and 2 yellow flags (PosiYellow, 6/10 points): Annual report filed late (NT 10-K); Change of auditor (8-K Item 4.01).
For financial statements, ratio trends and score history, Go Deep →